PhRMA

AUGUST 2, 2022

In case you missed it, Saturday, July 30, marked the anniversary of Medicare. For 57 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans with certain medical needs. To celebrate, we are reflecting on the history of the program that benefits more than 60 million Americans. Unfortunately, some members of Congress are considering significant changes to Medicare that could have a devastating effect on millions of Americans.

130

130

Pharmacy Times

AUGUST 2, 2022

Health care facilities in counties with higher Black populations and in rural areas were less likely to serve as COVID-19 vaccination facilities during May 2021, indicating disparities in vaccine distribution.

Vaccines 139

Vaccines 139

Pharmaceutical Technology

AUGUST 2, 2022

Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Last year, the companies entered a strategic collaboration. Subsequently, technology transfer as well as scale-up from the lab bench to the commercial facility of Samsung were carried out in a period of seven months.

Vaccines 104

Vaccines 104

Pharmacy Times

AUGUST 2, 2022

Abbott will work with the FDA to expedite the review of their deep brain stimulation system to treat the life-threatening disease of treatment-resistant depression.

FDA 132

FDA 132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 2, 2022

Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial. The results of the IMscin001 study found that an injection of Tecentriq under the skin taking just a few minutes was non-inferior to a 30 to 60-minute infusion with the IV version in terms of pharmacokinetics – how the active ingredient behaves in the body after administration.

Chemotherapy 104

Chemotherapy FDA 104

Pharmacy Times

AUGUST 2, 2022

Using computational methods, the development of an HIV therapy cocktail based on the virus’ genetics was found to increase the efficacy of treatment.

139

139

Pharmacy Times

AUGUST 2, 2022

Over the next few years, undiagnosed breast cancer cases may add to the demand for more rigorous end-stage treatments and therapeutics.

144

144

Outsourcing Pharma

AUGUST 2, 2022

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics.

96

96

Pharmacy Times

AUGUST 2, 2022

For every 10% increase in daily intake of ultra-processed foods, people had a 25% higher risk of dementia, though the association is not proven to be causal.

132

132

pharmaphorum

AUGUST 2, 2022

Sosei Heptares has signed up a string of big pharma collaborators over the last few years, and one of them – AbbVie – has just expanded its partnership with a new to deal to apply the biotech’s G protein-coupled receptor (GPCR) expertise to the discovery of drugs for neurological diseases. The collaboration adds to an earlier drug discovery agreement in the area of immunology and inflammation which dates back to June 2020, suggesting AbbVie likes what it has seen in the earlier alliance.

Immunization 86

Immunization 86

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

AUGUST 2, 2022

A new case study found that depictions of diverse female scientists on social media inspired other women in STEM, but stereotypes of how women in STEM should look and dress persist in comments section.

123

123

PharmaVoice

AUGUST 2, 2022

How Seed Health is transforming the microbiome therapeutic market with its pharma-focused drug development approach.

105

105

Pharmacy Times

AUGUST 2, 2022

Submissions are based on 3 phase 3 clinical trials showing that the drug achieved the co-primary endpoints of clinical remission and endoscopic response as induction and maintenance treatment.

FDA 123

FDA 123

European Pharmaceutical Review

AUGUST 2, 2022

GSK has signed a framework contract with the European Commission’s (EC) Health Emergency Preparedness and Response Authority (HERA) for the reservation of future production and supply of 85 million doses of its pandemic influenza vaccine Adjupanrix [pandemic influenza vaccine (split virion, inactivated, adjuvanted)]. Influenza pandemics, in which a new strain to which there is little or no pre-existing immunity in the human population, are impossible to predict and could cause mild, moderate or

Vaccines 83

Vaccines Immunization 83

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

AUGUST 2, 2022

Transgender children were more susceptible to depression, anxiety, and other mental health issues than their cisgender counterparts.

132

132

European Pharmaceutical Review

AUGUST 2, 2022

New Phase II data demonstrates that treatment with Biogen’s litifilimab (BIIB059) was superior in reducing skin disease activity of cutaneous lupus erythematosus (CLE) to placebo over a period of 16 weeks. The results of the Phase II LILAC study Part B were published in The New England Journal of Medicine ( NEJM ). CLE, a type of lupus, is a chronic autoimmune skin disease.

Dosage 78

Dosage 78

Outsourcing Pharma

AUGUST 2, 2022

A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.

83

83

Pharmacy Times

AUGUST 2, 2022

Omadacycline (Nuzyra) is indicated for the treatment of adult patients with infections caused by susceptible microorganisms—community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

65

65

PharmaVoice

AUGUST 2, 2022

EverythingALS aims to speed drug development through improved diagnostics.

105

105

Pharmacy Times

AUGUST 2, 2022

Young age was associated with vaccine-related fears that lowered vaccine uptake and increased symptoms of dizziness and lightheadedness during vaccination.

Vaccines 65

Vaccines 65

Pharmaceutical Technology

AUGUST 2, 2022

The Health Emergency Preparedness and Response Authority (HERA) of the European Commission (EC) has entered a co-procurement framework contract for HIPRA HUMAN HEALTH’s bivalent recombinant protein Covid-19 vaccine. A total of 14 member states and countries are participating in this deal and can procure up to 250 million vaccine doses. . Once the HIPRA vaccine receives a positive assessment from the European Medicines Agency (EMA), this contract will aid in making the doses available rapidly to

Vaccines 64

Vaccines 64

Pharmacy Times

AUGUST 2, 2022

Pharmacists have a key role in monitoring patients on statin therapy and identifying statin intolerance.

73

73

Pharmaceutical Technology

AUGUST 2, 2022

The increasing digitisation of the healthcare sector is enabling real-time access to patient-related data in a manner that was not previously possible. With more healthcare facilities transitioning from paper charts to electronic records and electronic health records (EHRs) becoming more integrated and technologically advanced, EHRs are expected to drive big changes in the provision of healthcare and clinical research delivery.

Patient Care 64

Patient Care 64

Pharmacy Times

AUGUST 2, 2022

Pharmacists have the potential to help optimize treatment and maximize supportive care management for targeted therapies.

65

65

Pharmaceutical Technology

AUGUST 2, 2022

Sosei Heptares , a corporate brand of Sosei Group Corporation, has signed a new drug discovery partnership and option-to-license agreement with AbbVie for discovering, developing and marketing new therapies for neurological ailments. Under the deal, the companies will develop small molecules that can modulate new G protein-coupled receptor (GPCR) targets linked to neurological diseases.

59

59

InCrowd

AUGUST 2, 2022

Learn why a pharmaceutical company considering acquiring a new product asset in a space with noticeable market movement turned to InCrowd’s global qualitative and quantitative solutions to uncover opportunities in product administration and identify an unmet market need. Get the results in our latest case study. The post How Real-Time Data Helps Business Development Teams with New Product Acquisition Research appeared first on InCrowd.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Social Pharmacist

AUGUST 2, 2022

The constantly changing algorithms and the evolving industry significantly impact how Google and other search engines generate organic traffic for a website. SEO-friendly pharmacy businesses or websites benefit from higher visitor traffic, improved brand awareness, and increased customer conversion rates. Companies start generating leads from health services and practices.

52

52

Digital Pharmacist

AUGUST 2, 2022

On July 6th, 2022 the FDA revised the Emergency Use Authorization (EUA) for Paxlovid. With this update, licensed pharmacists were granted the ability to prescribe Paxlovid to eligible patients, with certain limitations existing to ensure the safety and correct use of the medication. In today’s blog post, we will discuss this approval and what pharmacies need to know.

FDA 52

FDA Hospitals 52

pharmaphorum

AUGUST 2, 2022

Heart failure. Heart failure is one of the main causes of disability and mortality from cardiovascular pathology, its incidence is steadily increasing. It develops as a result of decompensation of other diseases of the cardiovascular system, such as hypertension, arrhythmia, cardiomyopathy, inflammatory heart diseases, etc. In this case, there is fluid retention in the body, volume overload and the formation of edematous syndrome.

Hospitals 52

Hospitals 52

Pharmaceutical Commerce

AUGUST 2, 2022

With the business model changing and the patent cliff looming, Ashfield Engage's Chris Savage talks about what these upheavals mean for pharma companies, their sales reps, and their patients.

52

52

pharmaphorum

AUGUST 2, 2022

In May, another amyloid targeting drug for Alzheimer’s disease – AC Immune and Roche’s crenezumab – missed the mark in another clinical trial and looked destined for the scrap heap like so many drugs in the class before it. The failed phase 2 API-ADAD trial in a rare, inherited form of the disease came after Roche abandoned two other phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer’s, and seemed all but certain to spell the end of the programme.

Immunization 52

Immunization 52

Pharmaceutical Technology

AUGUST 2, 2022

The US Food and Drug Administration (FDA) has granted approval for the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) ’s Stelara (ustekinumab) to treat paediatric patients aged six years and above with active psoriatic arthritis (PsA). The latest approval was based on pharmacokinetic (PK) findings and extrapolation of the validated efficacy and current safety profile of Stelara in various Phase III clinical trials carried out in adult and paediatric moderate-to-severe plaque

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 2, 2022

Traditionally, the foundation of pharmaceutical sales has been in-person visits between sales representatives and healthcare professionals (HCPs), which include events, conferences, dinners, and in-office visits. However, during the COVID-19 pandemic, this came to a grounding halt—all face-to-face visits were canceled, and reps had to find new ways to engage HCPs.

Communication 52

Communication Patient Care 52

Pharmaceutical Commerce

AUGUST 2, 2022

How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies.

Clinic Management 52

Clinic Management Communication 52